Therapeutic Apheresis and Dialysis

Additional Abstract Submissions from the 4th World Congress of the International Society for Apheresis
pp. A1-A6(6)

Observation Survey and Invasive Trial of Chronic Dialysis Patients
pp. 1-2(2)
Author: Akiba, Takashi

An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2001)
pp. 3-32(30)
Authors: Patient Registration Committee,; Japanese Society for Dialysis Therapy,

The Efficacy and Safety of the New Heparin-induced Extracorporeal Low-density Lipoprotein Precipitation System (Plasmat Futura) in Comparison with the Currently used System (Plasmat Secura)
pp. 33-38(6)
Authors: Blessing, Frithjof; Wang, Ying; Nagel, Dorothea; Seidel, Dietrich

Comparative Analysis Between Dextran Sulfate Adsorption and Direct Adsorption of Lipoproteins in their Capability to Reduce Erythrocyte Adhesiveness/Aggregation in the Peripheral Blood
pp. 39-44(6)
Authors: Schechner, V; Berliner, S; Shapira, I; Justo, D; Hershcovici, T; Zeltser, D; Beigel, Y

Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant
pp. 45-51(7)
Authors: Nagase, Kazuko; Fukunaga, Ken; Ohnishi, Kunio; Kusaka, Takeshi; Matoba, Yoshika; Sawada, Koji

Long Daily Hemodialysis Sessions Correct Systemic Complications of Oxalosis Prior to Combined Liver-Kidney Transplantation: Case Report
pp. 52-55(4)
Authors: Díaz, Cándido; Gil Catalinas, Fernando; de Alvaro, Fernando; Torre, Alberto; Sánchez, Carmen; Costero, Olga

Review of Combination of Peritoneal Dialysis and Hemodialysis as a Modality of Treatment for End-stage Renal Disease
pp. 56-61(6)
Authors: PD + HD Combination Therapy Study Group0110110110110110111,